The Quay - 100 Queens Quay East, 3rd Floor
In Person
Toronto has been a leader in stem cell research since the 1960s, with a world-class biotech sector, top-ranked hospitals, and exceptional research capabilities. These strengths have fueled the rise of regenerative medicine in the region, focusing on replacing, repairing, or regenerating human cells, tissues, and organs. Toronto is positioned to support the development of cutting-edge technologies and therapies that can improve patient outcomes and drive the city's status as a global life sciences powerhouse.
Join us as we bring together key players to explore how we can collectively drive innovation, improve patient outcomes, and solidify Toronto's global competitive position in regenerative medicine.
- Gain insights from industry leaders on innovation and patient outcomes.
- Understand the role of research and collaboration in the sector's success.
- Explore the challenges and opportunities in commercializing regenerative medicine discoveries.
- Network with key players driving Toronto's global competitive position.
Agenda
8:00 – 8:30 am: Networking & Registration
8:30 – 8:35 am: Welcome Remarks
- Roselle Martino, EVP, Policy, Advocacy & Stakeholder Engagement, Toronto Region Board of Trade
8:35 – 8:45 am: Opening Remarks
- Alison Nankivell, CEO, MaRS Discovery District
8:45 – 9:05 am: Keynote Address: The future of Regenerative Medicine in the Toronto Region
- Dr. Michael May, President & CEO, Centre for Commercialization of Regenerative Medicine (CCRM)
9:05 – 9:10 am: Context Setting and Speaker Introduction
Dr. Maura Campbell, President and CEO, Ontario Bioscience Innovation Organization
9:10 – 9:20 am: Lightning Talk #1: Transforming Health with Regenerative Medicine
- Dr. Shaf Keshavjee, Chief of Clinical Innovation, University Health Network
9:20 – 9:30 am: Lightning Talk #2: Journey from Discovery to Commercialization
- Emily Titus, SVP, Notch Therapeutics
9:30 – 9:40 am: Lightning Talk #3: Overcoming Barriers to Commercialize Regenerative Medicine Innovation
- Mitch Sivilotti, President and CEO, OmniaBio Inc.
9:40 – 10:05 am: Panel Discussion and Audience Q&A
- Dr. Michael May, President & CEO, Centre for Commercialization of Regenerative Medicine (CCRM)
- Dr. Shaf Keshavjee, Chief of Clinical Innovation, University Health Network
- Emily Titus, SVP, Notch Therapeutics
- Mitch Sivilotti, President and CEO, OmniaBio Inc.
Moderator:
- Dr. Maura Campbell, President and CEO, Ontario Bioscience Innovation Organization
10:05 – 10:10 am: Closing Remarks
- Giles Gherson, President & CEO, Toronto Region Board of Trade
10:10 - 10:30 am: Networking
Speakers
Tickets & Registration
Individual:
- Member: $129
- Non-Member: $179
Table of 10:
- Member: $1,299
- Non-Member: $1,799